… L eading charities have provided biopharma company Neurolixis joint funding to test a new drug to reduce dyskinesia in people with … with biopharmaceutical company Neurolixis. This drug has shown potential in the lab for reducing dyskinesia — a common …

… 20, 2024, Massachusetts Governor Maura Healey (D) signed into law an economic development package that includes a … the 21,000 people living with Parkinson’s disease in the Commonwealth and those diagnosed in the future. The … and policymakers learn more about Parkinson’s and how to treat it by:  Determining accurate statewide rates of …

… At the start of the New Year, we posed a query to our Team Fox members, asking you to share your … who vowed to invest more time improving their health and getting fit this year, Team Fox is here to help you knock … South and North Rim of the canyon. *For those nervous about completing the trek, participants will have the option to …

… Join The Michael J. Fox Foundation’s (MJFF) mission to find better treatments and ultimately a cure. Whether you … learn more about disease.  Learn more through the links on how to get involved in each study. Please spread the word of … and find a trial site near you, please visit TempoStudies.com .  Study Assessing Protein Inhibitor : The PROSEEK trial …

… of the game, they didn’t know they had something else in common: a connection to Parkinson’s disease. Mike was diagnosed several years … says, “You’re not just sending in a check. You’re really showing that you care and raising awareness.” Phil says, …

… Objective/Rationale: There is a great need to develop new, readily accessible biomarkers — objective … early diagnosis and treatment of Parkinson’s disease (PD). However, to date, no successful diagnostic tests based on such biomarkers have been developed. To overcome the challenges preventing the discovery of …